Mr. Andrew Hull - 14 Jan 2024 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role
Director
Signature
/s/ Eric A Adams, attorney-in-fact for Mr. Andrew Hull
Issuer symbol
INM
Transactions as of
14 Jan 2024
Net transactions value
$0
Form type
4
Filing time
05 Mar 2024, 15:20:52 UTC
Previous filing
26 Dec 2023
Next filing
22 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INM Employee Stock Option (Expiration) Expiration (or cancellation) of long derivative position with value received $0 -42 -0.49% $0.000000 8,542 14 Jan 2024 Common shares 42 $307.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Converted from the Canadian dollar exercise price of C$412.50 using an exchange rate of C$1.3436 = $US1.00